Join
Live feed
·
PRReleasevia Quantisnow
Aquestive Therapeutics Inc. logo

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

ByQuantisnow·Wall Street's wire, on your screen.
AQST· Aquestive Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AQST (Aquestive Therapeutics Inc.) and more on Quantisnow.